SOURCE: CNS Response, Inc.

CNS Response, Inc.

September 21, 2010 10:30 ET

CNS Response CEO George Carpenter to Present at The Fifth Annual JMP Securities Healthcare Industry Conference

Carpenter's September 28 Presentation Rescheduled From 4:00 p.m. to 10:30 a.m.

ALISO VIEJO, CA--(Marketwire - September 21, 2010) -  CNS Response (OTCBB: CNSO) today announced that CEO George Carpenter will be presenting at JMP Securities Fifth Annual Healthcare Industry Conference to be held Monday, September 27, through Tuesday, September 28, at the New York Palace Hotel in New York, NY. Carpenter's presentation time has been rescheduled to 10:30 a.m., Tuesday, September 28, 2010. Institutional investors wishing to schedule a one-on-one meeting with Mr. Carpenter may do so by contacting JMP Securities' Kelly Weigel at KWeigel@LJFevents.com.

About CNS Response
Today, most physicians are able to base treatment on objective test data, such as EKGs, MRIs, blood tests, etc. Broadly speaking, such advances have not yet come to those physicians practicing psychiatry.

Referenced-EEG was developed by physicians to provide objective, personalized, statistical data on patient neurophysiology. In clinical trials, physicians using rEEG® data have consistently achieved superior clinical results compared to physicians using trial and error pharmacotherapy.

The Company recently announced publication of results from its most recent clinical trial in The Journal of Psychiatric Research, in which physicians using Referenced-EEG (rEEG®) had success rates reaching 65 percent for patients with treatment-resistant depression.

To read more about the benefits this patented technology provides physicians, patients and insurers, please visit the CNS Response website, www.cnsresponse.com.

Contact Information

  • Investor and Media Relations:
    Marty Tullio
    Managing Partner
    McCloud Communications, LLC
    949.553.9748
    Email Contact